Fox Run Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-59,079
Closed -$715K 985
2024
Q4
$715K Buy
+59,079
New +$773K 0.13% 301
2024
Q3
Sell
-88,992
Closed -$1.28M 878
2024
Q2
$1.28M Buy
+88,992
New +$1.42M 0.24% 109
2024
Q1
Sell
-32,938
Closed -$491K 841
2023
Q4
$491K Sell
32,938
-41,551
-56% -$471K 0.13% 303
2023
Q3
$837K Buy
74,489
+48,329
+185% +$561K 0.25% 117
2023
Q2
$263K Sell
26,160
-20,724
-44% -$192K 0.07% 493
2023
Q1
$441K Buy
+46,884
New +$553K 0.14% 259
2022
Q4
Sell
-24,021
Closed -$298K 692
2022
Q3
$298K Buy
+24,021
New +$420K 0.12% 338
2022
Q1
Sell
-35,492
Closed -$1.01M 553
2021
Q4
$1.01M Buy
+35,492
New +$1.1M 0.59% 6
2021
Q3
Sell
-14,456
Closed -$501K 507
2021
Q2
$501K Buy
+14,456
New +$477K 0.46% 45
2020
Q4
Sell
-8,883
Closed -$248K 215
2020
Q3
$248K Buy
+8,883
New +$225K 0.62% 75
2020
Q1
Sell
-18,548
Closed -$546K 185
2019
Q4
$546K Buy
+18,548
New +$504K 0.44% 32

Other funds holding ELAN

Fox Run Management's ELAN Position: Q1 2025 in Review

Fox Run Management sold out of Elanco Animal Health (ELAN) in Q1 2025, closing a stake of 59,079 shares — an estimated $715K sold.

Fox Run Management first reported a position in ELAN in Q4 2019 and held it in 11 quarters. The position peaked at $1.28M in Q2 2024. 364 funds tracked by Wall St. Rank hold ELAN as of Q1 2025.

  • Fox Run Management reported no remaining Elanco Animal Health position as of Q1 2025 after selling out during the quarter.
  • Fox Run Management sold 59,079 Elanco Animal Health shares in Q1 2025, an estimated $715K.
  • Fox Run Management first reported a position in Elanco Animal Health in Q4 2019 and held it in 11 quarters.
  • Fox Run Management's Elanco Animal Health position peaked at $1.28M in Q2 2024.
  • 364 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2025.

Based on Fox Run Management's 13F filing for Q1 2025, filed 13 May 2025.